KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $572.6 million.

  • Charles River Laboratories International's Cost of Revenue rose 69.21% to $572.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 1535.7%. This contributed to the annual value of $2.3 billion for FY2024, which is 216.89% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Cost of Revenue is $572.6 million, which was up 69.21% from $584.9 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Cost of Revenue high stood at $664.8 million for Q3 2023, and its period low was $318.5 million during Q4 2023.
  • Its 5-year average for Cost of Revenue is $545.1 million, with a median of $572.6 million in 2025.
  • In the last 5 years, Charles River Laboratories International's Cost of Revenue tumbled by 4718.82% in 2023 and then soared by 9513.16% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Cost of Revenue (Quarter) stood at $468.1 million in 2021, then increased by 28.85% to $603.1 million in 2022, then tumbled by 47.19% to $318.5 million in 2023, then surged by 95.13% to $621.5 million in 2024, then fell by 7.87% to $572.6 million in 2025.
  • Its Cost of Revenue was $572.6 million in Q3 2025, compared to $584.9 million in Q2 2025 and $577.4 million in Q1 2025.